New AI-Powered Lung Imaging Solution Launched at RSNA 2018

By MedImaging International staff writers
Posted on 26 Nov 2018

Image: LungPrint Discovery is designed as an artificial intelligence (AI)-powered lung analysis solution for radiologists (Photo courtesy of VIDA Diagnostics).

VIDA Diagnostics, Inc. (Coralville, IA, USA), a pulmonary imaging analytics company, launched LungPrint Discovery, an artificial intelligence (AI)-powered lung analysis solution for radiologists, at the Radiological Society of North America's (RSNA) 104th Scientific Assembly and Annual Meeting, held November 25-30 in Chicago, Ill., USA.

VIDA is focused on transforming pulmonary care through intelligence. Powered by a combination of AI and quality-controlled image analysis services, VIDA's solution aims to provide greater precision and personalization across a range of lung diseases, including cancer, emphysema, airway obstructive diseases, asthma and interstitial lung disease. Like a fingerprint, each lung is unique. The LungPrint family of products, starting with LungPrint Discovery, aims to reveal each patient's unique lung profile in a manner that is clinically meaningful and efficient, helping VIDA deliver on its mission to transform lung care through information and intelligence.

LungPrint Discovery, a part of the VIDA|vision Software Suite, provides fully automatic quantification of lung physiology and function, including both tissue and airway analysis. LungPrint Discovery also features an airway visualization called "Hyperion View" with the potential to significantly accelerate airway reading and interpreting the complex airway anatomy.

"I've had the opportunity to preview VIDA's LungPrint Discovery and it is a game-changer for the reporting of thoracic CT scans," said Dr. John Newell, Professor of Radiology at the University of Iowa. "It will empower radiologists to provide a richer set of quantitative CT lung information with a state-of-the-art CT report for the referring physician. The new airway display is remarkable."

"We are pleased to serve radiologists with a product that delivers on the promises of AI, namely greater and proven clinical precision in tandem with efficiency gains," said Susan A. Wood, PhD, CEO of VIDA. "Our solution continually evolves and is designed with leading clinicians and clinically validated through large-scale trials. With seamless integration into the radiology workflow, our best-in-class solution can be used with a broadening audience and make a greater impact on pulmonary patient care."

Related Links:
VIDA Diagnostics

Visit expo >

Mammo DR Retrofit Solution

DR Retrofit Mammography

Digital Radiography System

DR-300

Pocket Fetal Doppler

CONTEC10C/CL

Half Apron

Demi

Latest RSNA 2018 News

Channels

Radiography

view channel

Images in a 75-year-old woman who underwent routine screening mammography in 2022. Left mediolateral oblique views shown from prior screening mammograms: (A) 2015, (B) 2018, (C) 2019, and (D) 2021. In (E) 2022, a new mass developed in the left breast at the 6-o’clock position (arrow), with a (F) corresponding irregular mass at US (arrow). Subsequent US-guided core needle biopsy yielded invasive ductal carcinoma, grade 2. The deep learning 5-year risk scores gradually increased from 2.0 (2015) to 2.1 (2018), 3.4 (2019), 3.6 (2021), and 15.3 (2022). CMFN = centimeters from nipple, LT = left, TRANS = transverse (Photo courtesy of Radiological Society of North America)

AI Tool Predicts Five-Year Breast Cancer Risk from Mammograms

Breast cancer risk assessment during routine screening is difficult because many women who develop the disease have no known genetic mutations or family history. Static risk tools provide limited discrimination... Read more

Image: Screening mammograms and artificial intelligence (AI) score changes over time in two individuals with screen-detected cancer. Full-field digital mammograms show craniocaudal (top) and mediolateral (bottom) views of the left and right breast (Photo courtesy of Radiological Society of North America)

AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis

Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead... Read more

$Image: Kyushu University researchers use Dynamic Chest Radiography (DCR) to evaluate the severity of Pulmonary Regurgitation (PR), a common complication after treatment of the congenital heart disease Tetralogy of Fallot. The analysis only requires the patient to hold their breath for seven seconds for a sequence of images of their heart to be taken. The images are then analyzed and extracted into a waveform that can show the severity of PR. The new technique\\\'s detection accuracy of severe PR is 93%, with a sensitivity of 93% and a specificity of 94%. (Photo courtesty of Kyushu University/Yuzo Yamasaki)$

Rapid X-Ray Test Quantifies Pulmonary Regurgitation After Tetralogy of Fallot Repair

Tetralogy of Fallot is the most common cyanotic congenital heart defect and can leave patients with pulmonary valve regurgitation, a backward flow of blood into the right ventricle after repair.... Read more

Image credit: Shu-Han Chen / St. Paul’s Hospital / National Taiwan University

AI Tool Flags Osteoporosis Risk from Routine Chest X-Rays

Osteoporosis is a progressive loss of bone density that is often silent until a fracture occurs. Current screening frameworks concentrate on older women and select high-risk groups. Many men, younger adults,... Read more

MRI

view channel

Image: Video and scientific image caption: Demonstration of ELITE results in two patients — a technology that provides high temporal and spatial resolution, reduces noise, and enhances the visualization of breast tumor (marked in yellow) and blood vessels morphology (Photo courtesy of Dr. Eddy Solomon/Technion - Israel Institute of Technology)

AI Reconstruction Tool Speeds Dynamic Breast MRI and Improves Cancer Detection

Breast cancer affects about 2.3 million people each year, creating sustained demand for precise imaging. Dynamic magnetic resonance imaging (MRI) is highly sensitive, yet slow acquisitions hinder real-time... Read more

International Study Assesses AI for Prostate Cancer MRI Interpretation

Prostate cancer is a leading cause of cancer morbidity in men, and accurate early diagnosis hinges on expert interpretation of prostate magnetic resonance imaging (MRI). Rapid adoption of MRI-first pathways... Read more

$Image: By training the AI with simulations, researchers can reconstruct brain images with high precision using only one-tenth of the data typically required in magnetic resonance imaging. The image shows a metric known as “fractional anisotropy”—an index of myelination—obtained using conventional methods and with the new approach (Photo courtesy of Instituto de Neurociencias UMH CSIC)$